Mir Imran, Chairman of the Board
Mir's passion is to create and commercialize breakthrough medical innovations. Mir founded InCube Labs, an R&D lab which has launched a number of life sciences companies including Fe3 Medical. After attending medical school, Mir began his career as a healthcare entrepreneur in the late 1970's and has founded numerous game-changing companies since those early days. Over the decades, he has become one of the leading inventors and entrepreneurs in the field. Mir now holds more than 200 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. As an entrepreneur, Mir has founded more than 20 life sciences companies; 15 of his companies have seen "liquidity events" (IPO/Acquisition). Mir's expertise spans a wide range of clinical areas from interventional cardiology to chronic pain, obesity and CNS disorders. Mir actively collaborates with the nation's top universities on research and development including Stanford, Rutgers, Johns Hopkins, UTSW, etc. Mir also founded InCube Ventures, a life sciences venture fund, where he has led investments in a range of promising ventures. Mir sits on Boards of several life sciences companies. He holds an M.S. in bioengineering and a B.S. in electrical engineering from Rutgers. He also attended CMDNJ/Rutgers Medical School.
Mark Sieczkarek, CEO
Mark has more than 35 years of leadership experience in the medical industry that included pharmaceutical, diagnostics, consumer products and medical device. Mark was past CEO and Chairman of the Board of Solta Medical, Inc. until it was acquired by Valeant Pharmaceuticals International, Inc. He served as President and Chief Executive Officer of Conceptus, Inc. from 2003 to 2011 prior to its sale to Bayer Pharmaceuticals in 2013. Previously, he was Senior Vice President and President of The Americas Region, responsible for the commercial operation of all Bausch & Lomb businesses in the United States, Canada and Latin America. He also served B&L as President of Europe. Mark joined Bausch & Lomb in 1995 as Vice President and Controller in the Personal Products division and also served as a Vice President in Corporate Business Development. Previously, Mark held an executive level position with KOS Pharmaceuticals, several Bristol Myers-Squibb subsidiaries and Sanofi Diagnostics Pasteur.
He has recently been named Chairman of the Board for NovaBay, a NYSE biotech company located in Emeryville and has served there as a director since January 2014. He has also served on the board of trustees of St John Fisher College in Rochester, N.Y.
Mark received a MBA degree in Finance from Canisius College in Buffalo, NY., and a B.S. degree in Accounting from the State University of New York at Buffalo.
Phil Morgan, President
Phil Morgan brings more than 20 years of pharmaceutical research and development experience to Fe3 Medical. Phil has extensive experience in drug development, drug-device combination therapies and the regulatory approval process. In addition to his role at Fe3 Medical, Phil is General Manager for InCube Labs' San Antonio operation, an R&D lab focused on creating and commercializing breakthrough medical innovations. Prior to his current role, Phil co-founded several successful life science companies and served as the president and CEO of Cytospect, Cytoscan and Neurotherapeutics. Before that, he was the Head of the Department of Molecular Pharmacology and a Senior Scientist at GlaxoSmithKline and a Visiting Fellow and Scientist at the National Institutes of Health, Bethesda, MD. Phil has published over 50 peer-reviewed articles and holds a PhD from London University and an MBA from Duke University.
Syed Zaidi, Vice President, Finance & Administration
Syed is an industry veteran with more than 25 years of experience in accounting, HR and operations. Syed has been instrumental in launching and running operations for more than a dozen InCube Lab start-ups in the last 15 years. Syed received his MBA from Osmania University in Hyderabad, India.
Ross Davidson, Secretary
Ross serves as Fe3 Medical's secretary, supporting the company's board of directors and management. A shareholder at Cox Smith, Ross represents various emerging technology companies and other clients on a variety of business transactions, including mergers and acquisitions, venture capital financings, joint ventures, securities offerings and domestic and international commercial transactions. Ross also regularly advises clients on corporate governance, organizational and contract matters and compliance with federal and state securities laws.